MOLECULAR DESIGN OF NOVEL PHARMACEUTICAL COMPOUNDS BASED ON TRANSITION STATE STR...
MOLECULAR DESIGN OF NOVEL PHARMACEUTICAL COMPOUNDS BASED ON TRANSITION STATE STRUCTURES ACCESSED VIA KINETIC ISOTOPE EFFECTS AN EXPERIMENTAL AND THEORETICAL STUDY
This project will contribute towards the molecular design of analogues of transition state structures associated with the degradation of therapeuticals. It will train an essentially computational chemist in experimental techniques...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2010-20822-C02-01
HERRAMIENTAS Y ESTRATEGIAS SINTETICAS PARA LA PREPARACION DE...
393K€
Cerrado
RTI2018-096344-B-I00
PLANTILLAS PEPTIDICAS RESTRINGIDAS PARA EL DISEÑO DE FARMACO...
57K€
Cerrado
SAF2008-04242
SINTESIS Y EVALUACION DE NUEVOS AGENTES ANTITUMORALES BASADO...
103K€
Cerrado
metabolicomp
Computational dynamics studies of drug metabolism by P450 en...
183K€
Cerrado
PID2019-104767RB-I00
LOS CARBOHIDRATOS Y EL AZUFRE COMO HERRAMIENTAS BASICAS EN E...
91K€
Cerrado
CSIC13-4E-1895
Determinación de propiedades físico-químicas en las etapas t...
42K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
This project will contribute towards the molecular design of analogues of transition state structures associated with the degradation of therapeuticals. It will train an essentially computational chemist in experimental techniques, allowing her to become an independent research with broad experience in isotopic studies. The specific experimental training objective of the project is the determination of kinetic isotope effects to interpret the reaction mechanisms of degradation. This will require the synthesis of isotopically-labelled target compounds and the study of their metabolism in vitro in mammalian and bacterial cell cultures. The project is an integral part of a programme researching the molecular mechanisms associated with the metabolism of therapeutic agents and their improvement through enhanced stability. It will focus on nicotine- and tropine-based compounds that are currently medicaments or are in evaluation as potential medicaments. These have a wide range of therapeutic activities: control of tobacco dependency; alleviation of addiction; treatment of neurodegenerative diseases; muscle relaxants. Instability of bioactive compounds presents a serious problem in drug design. The response adopted is frequently the use of higher doses, often associated with deleterious side-effects. A better understanding of the pharmacokinetics can allow a lower dose to be prescribed. Degradation often involves a dominant role for cytochrome P450-dependent oxidases through N-demethylation, oxidation, or ring cleavage. Improved resistance by structural modification or the use of a specific inhibitor will lead to improved therapy. The Host Laboratory has a strong experience in the experimental determination of isotopes in natural products by mass and NMR spectrometries. Acquiring these skills will complement the established abilities of the Researcher in the molecular modelling of reaction intermediates and transition states by in silico calculations of isotope effects.